While vaccination continues to play a major role in combating the COVID-19 virus, doctors across the world have been using various other innovative medical techniques, therapies to treat coronavirus patients.
Hospital begins monoclonal antibody treatment
Updated:
Updated:
Drug is said to bring down hospitalisation by 70%
Share Article
Drug is said to bring down hospitalisation by 70%
Kauvery Hospital in Chennai has treated a mildly symptomatic but high-risk COVID-19 patient with the monoclonal antibody cocktail that has been approved for emergency use in India. A statement issued by the hospital claimed that this was the first time the treatment had been used by a hospital in Tamil Nadu.
The individual was a cancer patient, who was recently diagnosed with early onset of renal failure, and hence was at higher risk of developing severe complications due to COVID-19.
Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy
Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy
Dr Reddy said use of antibody cocktail treatment for Covid-19 patients can help them recover from the disease within one week. However, the treatment should be given only in hospital settings.